In preclinical studies by Crudele et al. that used hyperfunctional factor IX (FIX-Padua, arginine 338 to leucine) in canine models of hemophilia B, expression of FIX-R338L post-gene transfer did not lead to inhibitor formation. Here, F9 is linked to hemophilia B.